The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...
Natural killer (NK) cells play a central role within the innate immune system and are able to recognize abnormal cells without prior sensitization. In recent years, NK cell–based ...